TrialThe journal of nutrition, health & aging2024

Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty.

Suvimol Niyomnaitham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.